AstraZeneca
-
FTSE 100 Stumbles as AstraZeneca Sell-Off Offsets Market Gains
The FTSE 100 fell 0.1% on Monday as a 9% slump in AstraZeneca shares outweighed gains from falling oil prices and strong performance in the housebuilding sector.
-
FTSE 100 Dips as AstraZeneca Trial Failure Offsets Mining Gains
The FTSE 100 dipped 0.2% as AstraZeneca’s trial failure offset mining gains, while the FTSE 250 rose 1% on positive earnings, signaling ongoing market volatility.
-
AstraZeneca and Trump’s Drug Pricing Deal
AstraZeneca and the Trump administration struck a landmark deal to reduce U.S. drug prices using a ‘most-favored-nation’ pricing model, with major implications for healthcare affordability and pharmaceutical policy.